Still own EVGN. For these types of investments I use a 2-4 yr window and then reassess. I have a rather smallish position compared to my other biotechs. I still like their efforts, but this is a marathon, not a sprint.
I hope this does not turn into another DNA Plant Technology, DNAP. That one looked good, but never made it.
Market Data 
Markets 
AI
